J Stroke.  2021 May;23(2):285-288. 10.5853/jos.2021.00010.

Troponin Levels and Outcomes in Patients with Embolic Stroke of Undetermined Source

• Choi KH
• Kim JH
• Kim JM
• Kang KW
• Kim JT
• Choi SM
• Park MS
• Cho KH

• KMID: 2516419
• DOI: http://doi.org/10.5853/jos.2021.00010

Figure

• 

  Figure 1. Vascular events based on conventional troponin I levels. (A) Major adverse cerebrovascular and cardiovascular event (MACCE), (B) recurrent stroke, (C) acute myocardial infarction, (D) vascular death.

• 

  Figure 2. Vascular events based on high-sensitivity troponin T levels. (A) Major adverse cerebrovascular and cardiovascular event (MACCE), (B) recurrent stroke, (C) acute myocardial infarction, (D) vascular death.

• 

  Figure 3. Association between cardiac troponin levels and clinical outcomes after embolic stroke of undetermined source. (A) Troponin I, (B) high-sensitivity troponin I (hs troponin-T). MACCE, major adverse cerebrovascular and cardiovascular event.

Reference

References

1. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13:429–438.

2. McCarthy CP, Raber I, Chapman AR, Sandoval Y, Apple FS, Mills NL, et al. Myocardial injury in the era of high-sensitivity cardiac troponin assays: a practical approach for clinicians. JAMA Cardiol. 2019; 4:1034–1042.

3. Merkler AE, Gialdini G, Murthy SB, Salehi Omran S, Moya A, Lerario MP, et al. Association between troponin levels and embolic stroke of undetermined source. J Am Heart Assoc. 2017; 6:e005905.

4. Ahn SH, Lee JS, Kim YH, Kim BJ, Kim YJ, Kang DW, et al. Prognostic significance of troponin elevation for long-term mortality after ischemic stroke. J Stroke. 2017; 19:312–322.

5. Scheitz JF, Pare G, Pearce LA, Mundl H, Peacock WF, Czlonkowska A, et al. High-sensitivity cardiac troponin T for risk stratification in patients with embolic stroke of undetermined source. Stroke. 2020; 51:2386–2394.